Global Injection Pen Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Injection Pen Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Injection Pen Market Size Growth Rate by Product
  • 1.4.2 Disposable injection pens
  • 1.4.3 Reusable injection pens
• 1.5 Market by End User
  • 1.5.1 Global Injection Pen Market Size Growth Rate by End User
  • 1.5.2 Home care
  • 1.5.3 Hospital & clinics
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Injection Pen Market Size
  • 2.1.1 Global Injection Pen Revenue 2014-2025
  • 2.1.2 Global Injection Pen Sales 2014-2025
• 2.2 Injection Pen Growth Rate by Regions
  • 2.2.1 Global Injection Pen Sales by Regions
  • 2.2.2 Global Injection Pen Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Injection Pen Sales by Manufacturers
  • 3.1.1 Injection Pen Sales by Manufacturers
  • 3.1.2 Injection Pen Sales Market Share by Manufacturers
  • 3.1.3 Global Injection Pen Market Concentration Ratio (CR5 and HHI)
• 3.2 Injection Pen Revenue by Manufacturers
  • 3.2.1 Injection Pen Revenue by Manufacturers (2014-2019)
  • 3.2.2 Injection Pen Revenue Share by Manufacturers (2014-2019)
• 3.3 Injection Pen Price by Manufacturers
• 3.4 Injection Pen Manufacturing Base Distribution, Product Types
  • 3.4.1 Injection Pen Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Injection Pen Product Type
  • 3.4.3 Date of International Manufacturers Enter into Injection Pen Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Injection Pen Sales by Product
• 4.2 Global Injection Pen Revenue by Product
• 4.3 Injection Pen Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Injection Pen Breakdown Data by End User

6 North America

• 6.1 North America Injection Pen by Countries
  • 6.1.1 North America Injection Pen Sales by Countries
  • 6.1.2 North America Injection Pen Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Injection Pen by Product
• 6.3 North America Injection Pen by End User

7 Europe

• 7.1 Europe Injection Pen by Countries
  • 7.1.1 Europe Injection Pen Sales by Countries
  • 7.1.2 Europe Injection Pen Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Injection Pen by Product
• 7.3 Europe Injection Pen by End User

8 Asia Pacific

• 8.1 Asia Pacific Injection Pen by Countries
  • 8.1.1 Asia Pacific Injection Pen Sales by Countries
  • 8.1.2 Asia Pacific Injection Pen Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Injection Pen by Product
• 8.3 Asia Pacific Injection Pen by End User

9 Central & South America

• 9.1 Central & South America Injection Pen by Countries
  • 9.1.1 Central & South America Injection Pen Sales by Countries
  • 9.1.2 Central & South America Injection Pen Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Injection Pen by Product
• 9.3 Central & South America Injection Pen by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Injection Pen by Countries
  • 10.1.1 Middle East and Africa Injection Pen Sales by Countries
  • 10.1.2 Middle East and Africa Injection Pen Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Injection Pen by Product
• 10.3 Middle East and Africa Injection Pen by End User

11 Company Profiles

• 11.1 Novo Nordisk
  • 11.1.1 Novo Nordisk Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Novo Nordisk Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Novo Nordisk Injection Pen Products Offered
  • 11.1.5 Novo Nordisk Recent Development
• 11.2 Sanofi
  • 11.2.1 Sanofi Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Sanofi Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Sanofi Injection Pen Products Offered
  • 11.2.5 Sanofi Recent Development
• 11.3 ELI Lilly
  • 11.3.1 ELI Lilly Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 ELI Lilly Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 ELI Lilly Injection Pen Products Offered
  • 11.3.5 ELI Lilly Recent Development
• 11.4 Merck
  • 11.4.1 Merck Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Merck Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Merck Injection Pen Products Offered
  • 11.4.5 Merck Recent Development
• 11.5 Ypsomed
  • 11.5.1 Ypsomed Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Ypsomed Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Ypsomed Injection Pen Products Offered
  • 11.5.5 Ypsomed Recent Development
• 11.6 Astrazeneca
  • 11.6.1 Astrazeneca Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Astrazeneca Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Astrazeneca Injection Pen Products Offered
  • 11.6.5 Astrazeneca Recent Development
• 11.7 Roche
  • 11.7.1 Roche Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Roche Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Roche Injection Pen Products Offered
  • 11.7.5 Roche Recent Development
• 11.8 Becton, Dickinson
  • 11.8.1 Becton, Dickinson Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Becton, Dickinson Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Becton, Dickinson Injection Pen Products Offered
  • 11.8.5 Becton, Dickinson Recent Development
• 11.9 Owen Mumford
  • 11.9.1 Owen Mumford Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Owen Mumford Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Owen Mumford Injection Pen Products Offered
  • 11.9.5 Owen Mumford Recent Development
• 11.10 Novartis
  • 11.10.1 Novartis Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Novartis Injection Pen Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Novartis Injection Pen Products Offered
  • 11.10.5 Novartis Recent Development
• 11.11 Pfizer
• 11.12 Haselmeier

12 Future Forecast

• 12.1 Injection Pen Market Forecast by Regions
  • 12.1.1 Global Injection Pen Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Injection Pen Revenue Forecast by Regions 2019-2025
• 12.2 Injection Pen Market Forecast by Product
  • 12.2.1 Global Injection Pen Sales Forecast by Product 2019-2025
  • 12.2.2 Global Injection Pen Revenue Forecast by Product 2019-2025
• 12.3 Injection Pen Market Forecast by End User
• 12.4 North America Injection Pen Forecast
• 12.5 Europe Injection Pen Forecast
• 12.6 Asia Pacific Injection Pen Forecast
• 12.7 Central & South America Injection Pen Forecast
• 12.8 Middle East and Africa Injection Pen Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Injection Pen Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details